Carregant...

Abc1p Is a Multidrug Efflux Transporter That Tips the Balance in Favor of Innate Azole Resistance in Candida krusei

Most Candida krusei strains are innately resistant to fluconazole (FLC) and can cause breakthrough candidemia in immunocompromised individuals receiving long-term prophylactic FLC treatment. Although the azole drug target, Erg11p, of C. krusei has a relatively low affinity for FLC, drug efflux pumps...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Lamping, Erwin, Ranchod, Amrita, Nakamura, Kenjirou, Tyndall, Joel D. A., Niimi, Kyoko, Holmes, Ann R., Niimi, Masakazu, Cannon, Richard D.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology (ASM) 2009
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2630665/
https://ncbi.nlm.nih.gov/pubmed/19015352
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01095-08
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!